Anagliptin, a potent dipeptidyl peptidase IV inhibitor: its single-crystal structure and enzyme interactions

YS Watanabe, Y Yasuda, Y Kojima… - Journal of Enzyme …, 2015 - Taylor & Francis
YS Watanabe, Y Yasuda, Y Kojima, S Okada, T Motoyama, R Takahashi, M Oka
Journal of Enzyme Inhibition and Medicinal Chemistry, 2015Taylor & Francis
The single-crystal structure of anagliptin, N-[2-({2-[(2 S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}
amino)-2-methylpropyl]-2-methylpyrazolo [1, 5-a] pyrimidine-6-carboxamide, was
determined. Two independent molecules were held together by intermolecular hydrogen
bonds, and the absolute configuration of the 2-cyanopyrrolidine ring delivered from l-
prolinamide was confirmed to be S. The interactions of anagliptin with DPP-4 were clarified
by the co-crystal structure solved at 2.85 Å resolution. Based on the structure determined by …
Abstract
The single-crystal structure of anagliptin, N-[2-({2-[(2S)-2-cyanopyrrolidin-1-yl]-2-oxoethyl}amino)-2-methylpropyl]-2-methylpyrazolo[1,5-a]pyrimidine-6-carboxamide, was determined. Two independent molecules were held together by intermolecular hydrogen bonds, and the absolute configuration of the 2-cyanopyrrolidine ring delivered from l-prolinamide was confirmed to be S. The interactions of anagliptin with DPP-4 were clarified by the co-crystal structure solved at 2.85 Å resolution. Based on the structure determined by X-ray crystallography, the potency and selectivity of anagliptin were discussed, and an SAR study using anagliptin derivatives was performed.
Taylor & Francis Online